Top Bioinformatics Startups in 2026

Raeva turns your wearable data into personal predictive insights, helping you understand your body and make informed decisions for your personal fitness and wellness. Learn more: raeva.fit

At Anivive, we are using software and cutting-edge technologies to change the landscape of pet health. We are developing a diverse suite of technologies to address the unmet medical needs of our pets. Not only do we work to bring new treatments to our pets but we also believe that improving pet health is much more than just developing novel treatments and our software tools help change the way we interact and care for our pets. We accomplish this by combining artificial intelligence software, biotech, and thoughtful design to change the way new therapies are discovered, developed, and used by people worldwide. Our mission is to use technology to make pet medicine more affordable. Our goal is to change the way people interact with and understand pet health.

Mammoth biosciences is harnessing the diversity of nature to power the next generation of crispr products. through its discovery of novel crispr systems, the company is enabling the full potential of its platform to read and write the code of life. with a distinguished team including co-founder and crispr-cas gene editing co-inventor jennifer doudna, mammoth is addressing challenges across healthcare, agriculture, environmental monitoring, biodefense, and more.

Our product accelerates the processing of DNA sequencing data. It is about 5x faster, uses 20x less power and requires 15x less space than conventional CPU solutions. We believe that the arrival of personal genomics in the next 2 to 5 years will bring huge computational requirements that will put large demands on conventional compute solutions. Our product is faster, cheaper and more compact.

We are developing Signal-X™, a multi-cancer platform able to detect various types of high-burden cancers with high sensitivity and tissue-of-origin specificity.

Novaflow is an AI-powered bioinformatics platform that lets life-science researchers upload raw sequencing data and get publication-ready plots in minutes instead of weeks—no code or bioinformatics team required.

Informuta is an infectious disease intelligence company that forecasts drug resistance trajectories to guide antibiotic selection with precision and quantify treatment-emergent resistance risk for the first time. Informuta uses proprietary AI and novel predictive genomic biomarkers to give clinicians the confidence to choose therapies that won’t fail their most vulnerable patients - transforming antibiotic prescribing from reactive to predictive and empowering smarter, future-proofed decisions.